Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Daclizumab in Patients With Chronic, Persistent Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00028288
Recruitment Status : Completed
First Posted : December 20, 2001
Last Update Posted : March 13, 2012
Information provided by (Responsible Party):
Facet Biotech

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2003
Actual Study Completion Date : December 2003